|

Mibavademab Clinical Trials

1 actively recruiting trial

Also known as: REGN4461

Pipeline

Phase 3: 1

Top Sponsors

  • Regeneron Pharmaceuticals1

Indications

  • Monogenic Obesity1
  • Weight Loss1

Other1 trial

A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.